In light of medicare advancements and the rising prevalence of life-threatening diseases, healthcare professionals are gradually making a shift toward injectable drug delivery systems from the hitherto oral medication solutions. The injectable drug delivery market is, according to industry analysis, estimated to be around a staggering US$ 49.44 billion, as of 2024. With the integration of telemedicine services, in the developing and developed parts of the world, this market is further slated to follow an upward surge.
Pharmaceutical companies in this industry are also leveraging this opportunity by curating more efficient devices, such as injectable, prefilled syringes, auto-injectors, and pen-injectors, for treating chronic and age-related conditions such as diabetes, hypertension, and arthritis. This has fueled the market to grow at a healthy CAGR of 8.70% through 2034.
The largest consumer group the companies are targeting in this market are the patients diagnosed with diabetes. In the United States alone, over 11.6% of the total population has diabetes at some level. This has set the right precedent for companies involved in this industry to market their offerings in the country. With the prevalence of diabetes and chronic diseases growing globally, the valuation is prone to hit US$ 113.87 billion by the end of 2034.
| Attributes | Details |
|---|---|
| Market Value for 2024 | US$ 49.44 billion |
| Projected Market Value for 2034 | US$ 113.87 billion |
| Value-based CAGR of the Market (2024 to 2034) | 8.70% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Many devices come under the purview of injectable drug delivery solutions such as self-injectors, needle-free injectors, auto-injectors, wearable injectors, and insulin pins. The insulin pins segment is expected to hold the predominant market share of 50.50% as of 2024.
| Attributes | Details |
|---|---|
| Product Type | Insulin Pins |
| Market Share (2024) | 50.50% |
On the basis of technology, injectable drug delivery systems are bifurcated into non-smart injectors and smart injectors. The former is slated to hold a market share of 83.80% as of 2024.
| Attributes | Details |
|---|---|
| Technology | Non-smart injectors |
| Market Share (2024) | 83.80% |
The biggest factor why medical professionals, even patients using injectable drug delivery systems, prefer non-smart injectors is due to their affordability. This makes them accessible to a wider range of consumers, especially those living in underdeveloped parts of the world.
Familiarity is another reason why lots of medical professionals choose non-smart injectors over smart ones. Apart from this, these injectors are simple to use and typically have straightforward mechanisms that require less training.
Principal Consultant
| Countries | CAGR (2024 to 2034) |
|---|---|
| China | 10.10% |
| Brazil | 9.80% |
| India | 9.50% |
| United Kingdom | 8.80% |
| Japan | 8.50% |
The market in China is a promising one. It is slated to progress at a CAGR of 10.10% through 2034.
The Chinese government since the pandemic has invested billions of dollars in making their healthcare system more advanced, sophisticated, and mechanized. This has led to a multitude of collaborations within the industry which is not only enhancing healthcare infrastructure but also increasing the adoption of modern equipment such as automatic injectors, needle-less drug delivers, etc.
For instance, in July 2021, Aptar announced the acquisition of 80% equity in Weihai Hengyu Medical Products Co., Ltd., bolstering its presence in China's market. This move aimed to enhance local manufacturing capacity and better serve regional and global customers.
Brazil is a lucrative country for the market. The market is anticipated to surge at a CAGR of 9.80% in the country.
According to a recent survey by NCBI, sexually transmitted diseases in Brazil have taken a tremendous jump by growing at a rate of 21% from 2010. This has forced drug delivery companies to curate injectable drugs and devices to combat this escalating health crisis.
A multitude of companies have already applied for approvals from the regulatory bodies in Brazil. For example, in June 2023, Brazil’s federal health regulator Anvisa approved injectable cabotegravir, a pre-exposure prophylaxis (PrEP) medication for HIV AIDS.
The India injectable drug delivery market is likely to flourish in the coming years. It is slated to inflate at a CAGR of 9.50% through 2034.
Since the pandemic, the Indian drug delivery market has seen a tremendous upward trend. Government as well as private healthcare companies are pouring billions of dollars into curating efficient devices and methodologies for drug deliveries to battle the nation's rising prevalence of chronic diseases.
The industry-academia collaboration has also benefited the market. For instance, in September 2019, Indian Institute of Technology Guwahati (IIT Guwahati) researchers developed nanomaterials from nature for controlled drug delivery, potentially targeting chemotherapy drugs directly to cancer cells, bypassing healthy cells.
The future of the United Kingdom injectable drug delivery market looks bright. The market is slated to rise at a CAGR of 8.80% through 2034 in the country.
The United Kingdom is currently dealing with the problem of rising obesity rates among its general population. The Health Survey for England 2021 estimates that 25.9% of adults in England are obese, which has forced medicare companies to curate weight-loss injectables. For instance, the United Kingdom’s Medicines and Healthcare Products Regulatory Agency recently approved Eli Lilly’s injectable diabetes medication for use as a weight loss treatment.
The market in Japan is slated to develop at a CAGR of 8.50% for the forecasted period of 2024 to 2034.
Japan is currently dealing with the problem of a growing aging population. This has pushed companies in the market to curate injectable drug delivery solutions that allow patients to take medications for chronic diseases, like hypertension, Alzheimer's, etc., at home.
For example, Japanese pharmaceutical company Eisai has planned to develop lecanemab, the Alzheimer's disease drug that has been approved in the USA for intravenous administration, so that it can be easily injected subcutaneously by patients or caregivers at home.
The market is an ever-evolving one with innovations and methodologies making constant entries into the market. With international companies investing billions of dollars in curating new devices and medical procedures for the healthcare sector, the market is very likely to experience an upward trend.
Domestic companies are developing devices according to the country’s needs. For example, Japanese companies are developing products for problems related to the aging population, the United Kingdom for obesity, and India for chronic diseases.
Recent Developments
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market is expected to be worth US$ US$ 49.44 billion in 2024.
The injectable drug delivery market is expected to reach US$ 113.87 billion by 2034.
The market is in line to develop at a CAGR of 8.70% from 2024 to 2034.
Amgen Inc., Antares Pharma Inc., Becton Dickinson and Company, Consort Medical Plc (Bespak), Crossjet, and Medtronic plc, are some of the major players in the global injectable drug delivery market.
The market valuation in 2023 was US$ 45.26 billion.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Manufacturer 3.5.1.2. Mid-Level Participants (Traders) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2024 to 2034 5.3.1. Self-Injector 5.3.2. Needle Free Injectors 5.3.3. Auto-Injectors 5.3.4. Wearable Injectors 5.3.5. Insulin Pens 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Product Type, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Technology 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Technology, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Technology, 2024 to 2034 6.3.1. Non-Smart Injectors 6.3.2. Smart Injectors 6.4. Y-o-Y Growth Trend Analysis By Technology, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Technology, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Usage 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Usage, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Usage, 2024 to 2034 7.3.1. Disposable Injectors 7.3.2. Reusable Injectors 7.4. Y-o-Y Growth Trend Analysis By Usage, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Usage, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2019 to 2023 8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2024 to 2034 8.3.1. Anaphylaxis 8.3.2. Diabetes 8.3.3. Cardiovascular Disease 8.3.4. Multiple Sclerosis 8.3.5. Rheumatoid Arthritis 8.3.6. Cancer 8.4. Y-o-Y Growth Trend Analysis By Indication, 2019 to 2023 8.5. Absolute $ Opportunity Analysis By Indication, 2024 to 2034 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channel, 2019 to 2023 9.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2024 to 2034 9.3.1. Hospital Pharmacies 9.3.2. Drug Stores 9.3.3. Retail Pharmacies 9.3.4. Online Pharmacies 9.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023 9.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 10.1. Introduction 10.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023 10.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034 10.3.1. North America 10.3.2. Latin America 10.3.3. Western Europe 10.3.4. Eastern Europe 10.3.5. South Asia and Pacific 10.3.6. East Asia 10.3.7. Middle East and Africa 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. USA 11.2.1.2. Canada 11.2.2. By Product Type 11.2.3. By Technology 11.2.4. By Usage 11.2.5. By Indication 11.2.6. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Technology 11.3.4. By Usage 11.3.5. By Indication 11.3.6. By Distribution Channel 11.4. Key Takeaways 12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Brazil 12.2.1.2. Mexico 12.2.1.3. Rest of Latin America 12.2.2. By Product Type 12.2.3. By Technology 12.2.4. By Usage 12.2.5. By Indication 12.2.6. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Technology 12.3.4. By Usage 12.3.5. By Indication 12.3.6. By Distribution Channel 12.4. Key Takeaways 13. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. Germany 13.2.1.2. UK 13.2.1.3. France 13.2.1.4. Spain 13.2.1.5. Italy 13.2.1.6. Rest of Western Europe 13.2.2. By Product Type 13.2.3. By Technology 13.2.4. By Usage 13.2.5. By Indication 13.2.6. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Technology 13.3.4. By Usage 13.3.5. By Indication 13.3.6. By Distribution Channel 13.4. Key Takeaways 14. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. Poland 14.2.1.2. Russia 14.2.1.3. Czech Republic 14.2.1.4. Romania 14.2.1.5. Rest of Eastern Europe 14.2.2. By Product Type 14.2.3. By Technology 14.2.4. By Usage 14.2.5. By Indication 14.2.6. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Technology 14.3.4. By Usage 14.3.5. By Indication 14.3.6. By Distribution Channel 14.4. Key Takeaways 15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. India 15.2.1.2. Bangladesh 15.2.1.3. Australia 15.2.1.4. New Zealand 15.2.1.5. Rest of South Asia and Pacific 15.2.2. By Product Type 15.2.3. By Technology 15.2.4. By Usage 15.2.5. By Indication 15.2.6. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Technology 15.3.4. By Usage 15.3.5. By Indication 15.3.6. By Distribution Channel 15.4. Key Takeaways 16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 16.2.1. By Country 16.2.1.1. China 16.2.1.2. Japan 16.2.1.3. South Korea 16.2.2. By Product Type 16.2.3. By Technology 16.2.4. By Usage 16.2.5. By Indication 16.2.6. By Distribution Channel 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Product Type 16.3.3. By Technology 16.3.4. By Usage 16.3.5. By Indication 16.3.6. By Distribution Channel 16.4. Key Takeaways 17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 17.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 17.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 17.2.1. By Country 17.2.1.1. GCC Countries 17.2.1.2. South Africa 17.2.1.3. Israel 17.2.1.4. Rest of MEA 17.2.2. By Product Type 17.2.3. By Technology 17.2.4. By Usage 17.2.5. By Indication 17.2.6. By Distribution Channel 17.3. Market Attractiveness Analysis 17.3.1. By Country 17.3.2. By Product Type 17.3.3. By Technology 17.3.4. By Usage 17.3.5. By Indication 17.3.6. By Distribution Channel 17.4. Key Takeaways 18. Key Countries Market Analysis 18.1. USA 18.1.1. Pricing Analysis 18.1.2. Market Share Analysis, 2023 18.1.2.1. By Product Type 18.1.2.2. By Technology 18.1.2.3. By Usage 18.1.2.4. By Indication 18.1.2.5. By Distribution Channel 18.2. Canada 18.2.1. Pricing Analysis 18.2.2. Market Share Analysis, 2023 18.2.2.1. By Product Type 18.2.2.2. By Technology 18.2.2.3. By Usage 18.2.2.4. By Indication 18.2.2.5. By Distribution Channel 18.3. Brazil 18.3.1. Pricing Analysis 18.3.2. Market Share Analysis, 2023 18.3.2.1. By Product Type 18.3.2.2. By Technology 18.3.2.3. By Usage 18.3.2.4. By Indication 18.3.2.5. By Distribution Channel 18.4. Mexico 18.4.1. Pricing Analysis 18.4.2. Market Share Analysis, 2023 18.4.2.1. By Product Type 18.4.2.2. By Technology 18.4.2.3. By Usage 18.4.2.4. By Indication 18.4.2.5. By Distribution Channel 18.5. Germany 18.5.1. Pricing Analysis 18.5.2. Market Share Analysis, 2023 18.5.2.1. By Product Type 18.5.2.2. By Technology 18.5.2.3. By Usage 18.5.2.4. By Indication 18.5.2.5. By Distribution Channel 18.6. UK 18.6.1. Pricing Analysis 18.6.2. Market Share Analysis, 2023 18.6.2.1. By Product Type 18.6.2.2. By Technology 18.6.2.3. By Usage 18.6.2.4. By Indication 18.6.2.5. By Distribution Channel 18.7. France 18.7.1. Pricing Analysis 18.7.2. Market Share Analysis, 2023 18.7.2.1. By Product Type 18.7.2.2. By Technology 18.7.2.3. By Usage 18.7.2.4. By Indication 18.7.2.5. By Distribution Channel 18.8. Spain 18.8.1. Pricing Analysis 18.8.2. Market Share Analysis, 2023 18.8.2.1. By Product Type 18.8.2.2. By Technology 18.8.2.3. By Usage 18.8.2.4. By Indication 18.8.2.5. By Distribution Channel 18.9. Italy 18.9.1. Pricing Analysis 18.9.2. Market Share Analysis, 2023 18.9.2.1. By Product Type 18.9.2.2. By Technology 18.9.2.3. By Usage 18.9.2.4. By Indication 18.9.2.5. By Distribution Channel 18.10. Poland 18.10.1. Pricing Analysis 18.10.2. Market Share Analysis, 2023 18.10.2.1. By Product Type 18.10.2.2. By Technology 18.10.2.3. By Usage 18.10.2.4. By Indication 18.10.2.5. By Distribution Channel 18.11. Russia 18.11.1. Pricing Analysis 18.11.2. Market Share Analysis, 2023 18.11.2.1. By Product Type 18.11.2.2. By Technology 18.11.2.3. By Usage 18.11.2.4. By Indication 18.11.2.5. By Distribution Channel 18.12. Czech Republic 18.12.1. Pricing Analysis 18.12.2. Market Share Analysis, 2023 18.12.2.1. By Product Type 18.12.2.2. By Technology 18.12.2.3. By Usage 18.12.2.4. By Indication 18.12.2.5. By Distribution Channel 18.13. Romania 18.13.1. Pricing Analysis 18.13.2. Market Share Analysis, 2023 18.13.2.1. By Product Type 18.13.2.2. By Technology 18.13.2.3. By Usage 18.13.2.4. By Indication 18.13.2.5. By Distribution Channel 18.14. India 18.14.1. Pricing Analysis 18.14.2. Market Share Analysis, 2023 18.14.2.1. By Product Type 18.14.2.2. By Technology 18.14.2.3. By Usage 18.14.2.4. By Indication 18.14.2.5. By Distribution Channel 18.15. Bangladesh 18.15.1. Pricing Analysis 18.15.2. Market Share Analysis, 2023 18.15.2.1. By Product Type 18.15.2.2. By Technology 18.15.2.3. By Usage 18.15.2.4. By Indication 18.15.2.5. By Distribution Channel 18.16. Australia 18.16.1. Pricing Analysis 18.16.2. Market Share Analysis, 2023 18.16.2.1. By Product Type 18.16.2.2. By Technology 18.16.2.3. By Usage 18.16.2.4. By Indication 18.16.2.5. By Distribution Channel 18.17. New Zealand 18.17.1. Pricing Analysis 18.17.2. Market Share Analysis, 2023 18.17.2.1. By Product Type 18.17.2.2. By Technology 18.17.2.3. By Usage 18.17.2.4. By Indication 18.17.2.5. By Distribution Channel 18.18. China 18.18.1. Pricing Analysis 18.18.2. Market Share Analysis, 2023 18.18.2.1. By Product Type 18.18.2.2. By Technology 18.18.2.3. By Usage 18.18.2.4. By Indication 18.18.2.5. By Distribution Channel 18.19. Japan 18.19.1. Pricing Analysis 18.19.2. Market Share Analysis, 2023 18.19.2.1. By Product Type 18.19.2.2. By Technology 18.19.2.3. By Usage 18.19.2.4. By Indication 18.19.2.5. By Distribution Channel 18.20. South Korea 18.20.1. Pricing Analysis 18.20.2. Market Share Analysis, 2023 18.20.2.1. By Product Type 18.20.2.2. By Technology 18.20.2.3. By Usage 18.20.2.4. By Indication 18.20.2.5. By Distribution Channel 18.21. GCC Countries 18.21.1. Pricing Analysis 18.21.2. Market Share Analysis, 2023 18.21.2.1. By Product Type 18.21.2.2. By Technology 18.21.2.3. By Usage 18.21.2.4. By Indication 18.21.2.5. By Distribution Channel 18.22. South Africa 18.22.1. Pricing Analysis 18.22.2. Market Share Analysis, 2023 18.22.2.1. By Product Type 18.22.2.2. By Technology 18.22.2.3. By Usage 18.22.2.4. By Indication 18.22.2.5. By Distribution Channel 18.23. Israel 18.23.1. Pricing Analysis 18.23.2. Market Share Analysis, 2023 18.23.2.1. By Product Type 18.23.2.2. By Technology 18.23.2.3. By Usage 18.23.2.4. By Indication 18.23.2.5. By Distribution Channel 19. Market Structure Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Market Share Analysis of Top Players 19.3.1. By Regional 19.3.2. By Product Type 19.3.3. By Technology 19.3.4. By Usage 19.3.5. By Indication 19.3.6. By Distribution Channel 20. Competition Analysis 20.1. Competition Deep Dive 20.1.1. Amgen Inc. 20.1.1.1. Overview 20.1.1.2. Product Portfolio 20.1.1.3. Profitability by Market Segments 20.1.1.4. Sales Footprint 20.1.1.5. Strategy Overview 20.1.1.5.1. Marketing Strategy 20.1.1.5.2. Product Strategy 20.1.1.5.3. Channel Strategy 20.1.2. Antares Pharma Inc. 20.1.2.1. Overview 20.1.2.2. Product Portfolio 20.1.2.3. Profitability by Market Segments 20.1.2.4. Sales Footprint 20.1.2.5. Strategy Overview 20.1.2.5.1. Marketing Strategy 20.1.2.5.2. Product Strategy 20.1.2.5.3. Channel Strategy 20.1.3. Becton Dickinson and Company 20.1.3.1. Overview 20.1.3.2. Product Portfolio 20.1.3.3. Profitability by Market Segments 20.1.3.4. Sales Footprint 20.1.3.5. Strategy Overview 20.1.3.5.1. Marketing Strategy 20.1.3.5.2. Product Strategy 20.1.3.5.3. Channel Strategy 20.1.4. Consort Medical Plc 20.1.4.1. Overview 20.1.4.2. Product Portfolio 20.1.4.3. Profitability by Market Segments 20.1.4.4. Sales Footprint 20.1.4.5. Strategy Overview 20.1.4.5.1. Marketing Strategy 20.1.4.5.2. Product Strategy 20.1.4.5.3. Channel Strategy 20.1.5. Crossjet 20.1.5.1. Overview 20.1.5.2. Product Portfolio 20.1.5.3. Profitability by Market Segments 20.1.5.4. Sales Footprint 20.1.5.5. Strategy Overview 20.1.5.5.1. Marketing Strategy 20.1.5.5.2. Product Strategy 20.1.5.5.3. Channel Strategy 20.1.6. Medtronic plc, 20.1.6.1. Overview 20.1.6.2. Product Portfolio 20.1.6.3. Profitability by Market Segments 20.1.6.4. Sales Footprint 20.1.6.5. Strategy Overview 20.1.6.5.1. Marketing Strategy 20.1.6.5.2. Product Strategy 20.1.6.5.3. Channel Strategy 20.1.7. Mylan N.V. 20.1.7.1. Overview 20.1.7.2. Product Portfolio 20.1.7.3. Profitability by Market Segments 20.1.7.4. Sales Footprint 20.1.7.5. Strategy Overview 20.1.7.5.1. Marketing Strategy 20.1.7.5.2. Product Strategy 20.1.7.5.3. Channel Strategy 20.1.8. SHL Group 20.1.8.1. Overview 20.1.8.2. Product Portfolio 20.1.8.3. Profitability by Market Segments 20.1.8.4. Sales Footprint 20.1.8.5. Strategy Overview 20.1.8.5.1. Marketing Strategy 20.1.8.5.2. Product Strategy 20.1.8.5.3. Channel Strategy 20.1.9. West Pharmaceutical Services 20.1.9.1. Overview 20.1.9.2. Product Portfolio 20.1.9.3. Profitability by Market Segments 20.1.9.4. Sales Footprint 20.1.9.5. Strategy Overview 20.1.9.5.1. Marketing Strategy 20.1.9.5.2. Product Strategy 20.1.9.5.3. Channel Strategy 20.1.10. Ypsomed 20.1.10.1. Overview 20.1.10.2. Product Portfolio 20.1.10.3. Profitability by Market Segments 20.1.10.4. Sales Footprint 20.1.10.5. Strategy Overview 20.1.10.5.1. Marketing Strategy 20.1.10.5.2. Product Strategy 20.1.10.5.3. Channel Strategy 21. Assumptions & Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Injectable Drug Delivery Market
